Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000526942 | SCV000640509 | benign | Nemaline myopathy 2 | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003129894 | SCV003811613 | uncertain significance | not provided | 2023-07-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003129894 | SCV004012408 | uncertain significance | not provided | 2023-07-07 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Natera, |
RCV000526942 | SCV002077067 | uncertain significance | Nemaline myopathy 2 | 2019-11-11 | no assertion criteria provided | clinical testing |